A clinical trial has found that oral semaglutide reduces heavy drinking in adults with Alcohol Use Disorder (AUD). The study evaluated the oral formulation of semaglutide, which may be more acceptable for people with AUD than the injectable formulations previously tested for AUD.

A clinical trial has found that oral semaglutide reduces heavy drinking in adults with Alcohol Use Disorder (AUD). The study evaluated the oral formulation of semaglutide, which may be more acceptable for people with AUD than the injectable formulations previously tested for AUD.